Cavitation Technologies Reports Mixed Q2 2025 Results Amid Revenue Drop and Patent Gains

Cavitation Technologies, Inc. (OTCBB: CVAT) recently reported its Q2 2025 financial results, highlighting a mixed performance on its income statement.

Key Highlights:

• Revenue: $76,000 for Q2 2025, a 60.4% decrease from $192,000 in Q2 2024.
• Gross Profit: $63,000, down 60.1% from $158,000 in the prior year.
• Net Income: $579,000 reported, compared to a net loss of $16,000 in the same quarter last year.
• Gain on Patent Assignment: $880,000 from the sale of patents to Desmet Ballestra, significantly boosting net income.
• General and Administrative Expenses (G&A): Increased by 101.2% to $346,000, largely due to stock compensation and legal fees.
• Loss from Operations: Recorded at $(299,000), a substantial increase from $(14,000) in the same quarter last year.
• Cash Position: Cash and cash equivalents stood at $681,000 as of December 31, 2024.
• Stockholders’ Deficit: Total stockholders’ deficit of $(23,000) indicates persistent financial challenges.

Positive Aspects:

• Despite a decline in regular revenue, the gain from patent assignments provided a significant boost to net income.
• The company capitalized on the intellectual property it possesses, generating $880,000 in cash inflow.
• The company retains a worldwide, exclusive license to utilize its technology, which opens up new market opportunities.

Negative Aspects:

• Revenue decline raises concerns about ongoing operational performance, with a year-over-year drop of 60.4%.
• General and administrative expenses have risen dramatically, contributing to a larger loss from operations.
• Substantial doubts remain regarding the company’s ability to continue as a going concern; highlighted by inconsistencies in income and elevated expenses.

In conclusion, while Cavitation Technologies, Inc. has demonstrated potential for growth through the monetization of patents, the significant decline in operational revenue and escalating costs pose serious challenges that management must address moving forward.